These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [The significance of leukotrienes in pathophysiology of bronchial asthma--therapy perspectives]. Wojnowski P; Patkowski J Postepy Hig Med Dosw; 1997; 51(5):499-514. PubMed ID: 9489451 [TBL] [Abstract][Full Text] [Related]
25. Involvement of leukotrienes in acute gastric damage. Boughton-Smith NK Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():53-9. PubMed ID: 2657289 [TBL] [Abstract][Full Text] [Related]
26. [The role of prostanoids in malignant diseases]. Navrátil L; Pospísil J Cas Lek Cesk; 1989 Jan; 128(2):37-40. PubMed ID: 2720734 [TBL] [Abstract][Full Text] [Related]
27. [Leukotrienes in allergic inflammatory reactions]. Bogić M; Rasković S; Perić-Popadić A; Tomić-Spirić V; Andrejević S; Jovicić Z Srp Arh Celok Lek; 1998; 126(9-10):382-7. PubMed ID: 9863412 [TBL] [Abstract][Full Text] [Related]
28. [New developments in asthma therapy: how do individual leukotriene antagonists work?]. Wagener M Praxis (Bern 1994); 1998 Feb; 87(8):271-5. PubMed ID: 9542455 [TBL] [Abstract][Full Text] [Related]
29. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. Hikiji H; Takato T; Shimizu T; Ishii S Prog Lipid Res; 2008 Mar; 47(2):107-26. PubMed ID: 18187046 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological activity of new leukotriene antagonists (racemates and enantiomerically pure compounds). Anagnostopulos C; Bartmann W; Beck G; Below P; Bergmann A; Linz W; Schacht U; Schölkens BA; Wess G Biomed Biochim Acta; 1988; 47(10-11):S190-3. PubMed ID: 3248106 [TBL] [Abstract][Full Text] [Related]
31. Summary: the pharmacology of leukotrienes in asthma. Costello J; Meltzer S; Bleecker ER Adv Prostaglandin Thromboxane Leukot Res; 1994; 22():263-8. PubMed ID: 7771340 [No Abstract] [Full Text] [Related]
32. Obituary for Professor Priscilla Piper. Costello J Prostaglandins; 1995 Jun; 49(6):319-22. PubMed ID: 7480801 [No Abstract] [Full Text] [Related]
33. Prostaglandins: an overview. McCarthy JA Adv Pediatr; 1978; 25():121-49. PubMed ID: 742549 [TBL] [Abstract][Full Text] [Related]
34. Prostanoids as pharmacological targets in COPD and asthma. Rolin S; Masereel B; Dogné JM Eur J Pharmacol; 2006 Mar; 533(1-3):89-100. PubMed ID: 16458293 [TBL] [Abstract][Full Text] [Related]
35. Leukotriene modifiers in the treatment of cardiovascular diseases. Riccioni G; Capra V; D'Orazio N; Bucciarelli T; Bazzano LA J Leukoc Biol; 2008 Dec; 84(6):1374-8. PubMed ID: 18794213 [TBL] [Abstract][Full Text] [Related]
36. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes. Böhler J; Donauer J; Birmelin M; Schollmeyer PJ; Hörl WH Nephrol Dial Transplant; 1993; 8(12):1359-65. PubMed ID: 8159305 [TBL] [Abstract][Full Text] [Related]
37. [The physiological role and significance of prostaglandins in the reaction of the body to unfavorable environmental factors]. Petrova TV; Bobrovnitskiĭ IP Kosm Biol Aviakosm Med; 1988; 22(5):6-14. PubMed ID: 3066985 [TBL] [Abstract][Full Text] [Related]
38. Substances with vasoactive effects mediated by the prostaglandin system. Pallapies D; Peskar BA Vasa Suppl; 1991; 33():75-6. PubMed ID: 1788770 [No Abstract] [Full Text] [Related]